Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo O Perez

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Diseases of the Colon and Rectum|September 12, 2013
Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?Angelita Habr-Gama, Jorge Sabbaga, Joaquim Gama-Rodrigues, et al.
Diseases of the Colon and Rectum|August 10, 2016
Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 6, 2007
Peritumoral inflammatory infiltrate is not a prognostic factor in distal rectal cancer following neoadjuvant chemoradiation therapyRodrigo O Perez, Angelita Habr-Gama, Rafael Miyashiro Nunes dos Santos, et al.
Annals of Surgery|April 5, 2019
Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over TimeGuilherme P São Julião, Georgios Karagkounis, Laura M Fernandez, et al.
Diseases of the Colon and Rectum|July 8, 2009
The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancerRodrigo O Perez, Guilherme P São Julião, Angelita Habr-Gama, et al.
Diseases of the Colon and Rectum|October 7, 2014
Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Annals of Surgery|October 1, 2019
Urethral Injury and Other Urologic Injuries During Transanal Total Mesorectal Excision: An International Collaborative StudyPatricia Sylla, Joep J Knol, Anthony P D'Andrea, et al.
Diseases of the Colon and Rectum|July 3, 2009
Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation?Rodrigo O Perez, Diego D Pereira, Igor Proscurshim, et al.
Radiation Oncology (London, England)|February 26, 2016
Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimenAngelita Habr-Gama, Rodrigo O Perez, Guilherme P São Julião, et al.
Annals of Surgery|May 3, 2019
Response to Comment on "Organ Preservation for cT2N0 Distal Rectal Cancer-Are There Any Better Surgical Alternatives Without Chemoradiation?"Angelita Habr-Gama, Guilherme P São Julião, Bruna B Vailati, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Diseases of the Colon and Rectum|September 12, 2013
Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?Angelita Habr-Gama, Jorge Sabbaga, Joaquim Gama-Rodrigues, et al.
Diseases of the Colon and Rectum|August 10, 2016
Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 6, 2007
Peritumoral inflammatory infiltrate is not a prognostic factor in distal rectal cancer following neoadjuvant chemoradiation therapyRodrigo O Perez, Angelita Habr-Gama, Rafael Miyashiro Nunes dos Santos, et al.
Annals of Surgery|April 5, 2019
Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over TimeGuilherme P São Julião, Georgios Karagkounis, Laura M Fernandez, et al.
Diseases of the Colon and Rectum|July 8, 2009
The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancerRodrigo O Perez, Guilherme P São Julião, Angelita Habr-Gama, et al.
Diseases of the Colon and Rectum|October 7, 2014
Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Annals of Surgery|October 1, 2019
Urethral Injury and Other Urologic Injuries During Transanal Total Mesorectal Excision: An International Collaborative StudyPatricia Sylla, Joep J Knol, Anthony P D'Andrea, et al.
Diseases of the Colon and Rectum|July 3, 2009
Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation?Rodrigo O Perez, Diego D Pereira, Igor Proscurshim, et al.
Radiation Oncology (London, England)|February 26, 2016
Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimenAngelita Habr-Gama, Rodrigo O Perez, Guilherme P São Julião, et al.
Annals of Surgery|May 3, 2019
Response to Comment on "Organ Preservation for cT2N0 Distal Rectal Cancer-Are There Any Better Surgical Alternatives Without Chemoradiation?"Angelita Habr-Gama, Guilherme P São Julião, Bruna B Vailati, et al.
Pageof 8